CANTON STRATEGIC HOLDINGS INC (CNTN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.28+1.33%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CNTN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of — · Company calendar date is not available
CNTN — debt issuance
Dated 2026-03-03
Material Definitive Agreement On March 3, 2026, Canton Strategic Holdings, Inc. (the “ Company ”), entered into an amended and restated sales agreement (the “ Sales Agreement ”) with Clear Street LLC (“ Clear Street ”) and Virtu Americas LLC (“ Virtu ”, and together with Clear Street, the “ Sales Agents ”), relating to the sale of shares of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”). The Sales Agreement amends and restates the ATM Sales Agreement, dated as…
Why it matters: Growing losses may show that the company faces ongoing problems. This is important for financial health.
Worry ifQ2 operating loss exceeds $36.9 million.
Less concerning ifQ2 operating loss improves or stays below $36.9 million.
Why it matters: Locking-as-a-Service (LaaS) revenue is a new way to make money. Growth here shows that the market is accepting the service.
Supportive ifLaaS revenue exceeds $1.5 million in the next quarter.
Worry ifLaaS revenue drops below $1 million in the next quarter.
Why it matters: The repurchase program shows that management believes in the company's value. This may help keep the share price steady.
Supportive ifThe company is buying back shares as part of the $50 million program.
Worry ifThe company does not repurchase any shares by the end of Q3 2026.
Why it matters: Staying compliant is crucial for maintaining the company's stock listing. Non-compliance could lead to delisting.
Worry ifThe company says it meets Nasdaq listing rules before the next earnings date.
Less concerning ifThe company does not meet Nasdaq rules, which may lead to delisting.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$352 on $10,000 · ±3.5% | How much price usually moves either way. |
| Bad day | $1,039 loss on $10,000 · 10.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,624 loss on $10,000 · 66.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Unlocking more Super Validator weight can help increase revenue and market share.
Supportive ifThe company unlocks at least 1 more Super Validator weight by next quarter.
Worry ifNo extra Super Validator weight will be unlocked next quarter.
Why it matters: Getting milestone payments shows that Gravitas' projects are developing well. This helps cash flow.
Supportive ifThe company says it got milestone payments from the Gravitas sale.
Worry ifNo milestone payments are reported by the end of Q4 2026.